Filter
3972
Filtered Results: 3972
Text search:
drug
strategy
Featured
Recommendations
349
New Publications
1161
Language
Document type
No document type
2484
Studies & Reports
610
Guidelines
463
Strategic & Response Plan
149
Manuals
146
Fact sheets
44
Training Material
42
Situation Updates
19
Infographics
10
Resource Platforms
4
Brochures
1
Countries / Regions
India
204
Global
138
Kenya
131
Uganda
104
Ethiopia
103
South Africa
100
Western and Central Europe
89
Nigeria
86
Nepal
80
Liberia
78
Malawi
72
Sierra Leone
70
Tanzania
66
Myanmar / Burma
65
Zambia
64
Latin America and the Carribbean
64
Africa
64
Ghana
56
Bangladesh
56
Rwanda
49
Eastern Europe
44
Namibia
40
Philippines
37
Ukraine
37
Cambodia
36
Asia
34
South–East Asia Region
32
Zimbabwe
31
Lesotho
28
Indonesia
24
Botswana
24
Russia
21
Syria
19
Colombia
18
Congo, Democratic Republic of
17
Mozambique
17
Senegal
15
East and Southern Africa
15
West and Central Africa
15
Brazil
14
Burkina Faso
13
Eswatini/ Swaziland
13
Middle East and North Africa
13
South Sudan
11
Thailand
10
Eastern Europe and Central Asia
10
Albania
10
USA
9
Cameroon
9
Pakistan
9
Sudan
9
Venezuela
9
Guinea
8
Tajikistan
8
Georgia
8
Haiti
7
Germany
7
Peru
7
Western Pacific Region
7
Vietnam
7
Afghanistan
6
Argentina
6
Laos
6
Jordan
4
China
4
Benin
4
North Macedonia
4
Sri Lanka
4
Yemen
4
Southern Africa
4
Moldova
4
Somalia
3
Iraq
3
Lebanon
3
Turkey
3
Central African Republic
3
El Salvador
3
Bolivia
3
Mexico
3
Paraguay
3
Bhutan
3
Timor Leste/ East Timor
3
Iran
3
Jamaica
3
Morocco
2
Papua New Guinea
2
Hungary
2
Honduras
2
Libya
2
Madagascar
2
Estonia
2
Uzbekistan
2
Kyrgyzstan
2
North America
2
United Kingdom
2
Portugal
2
Spain
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Gambia
1
Ireland
1
Austria
1
Switzerland
1
Serbia
1
Greece
1
Guatemala
1
Nicaragua
1
Chile
1
Poland
1
Palestine
1
North Korea
1
Armenia
1
Mongolia
1
Canada
1
Qatar
1
Bulgaria
1
Romania
1
Lithuania
1
Kazakhstan
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Authors & Publishers
Publication Years
Category
Countries
1629
Clinical Guidelines
352
Public Health
236
Women & Child Health
137
Key Resources
83
Capacity Building
51
Pharmacy & Technologies
39
Annual Report MEDBOX
1
Toolboxes
HIV
479
TB
424
Mental Health
300
AMR
204
NTDs
153
COVID-19
150
Pharmacy
91
NCDs
91
Rapid Response
74
Caregiver
64
Planetary Health
56
Ebola
51
Disability
45
Conflict
45
Global Health Education
44
Refugee
40
Health Financing Toolbox
28
Polio
20
Natural Hazards
14
Cholera
12
Specific Hazards
11
Zika
9
Social Ethics
7
The Strategy aims to protect and improve the well-being
of society and of the individual, to protect and promote
public health, to offer a high level of security and well-being
for the general public and to increase health literacy. The
... takes an evidence-based, integrated, balanced and
multidisciplinary approach to the drugs phenomenon at
national, EU and international level. It also incorporates a
gender equality and health equity perspective.
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact ...
A practical toolkit for young people who are passionate about advancing HIV and sexual and reproductive health and rights through national advocacy in the post-2015 agenda.
Framework for implementation.
The END TB Strategy.
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resis...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not b...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty ...
Countries, partners, and donors are committed to
the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more
than funding; it requires health personnel with the
right mix of skills, and well supported and managed
health systems. Mass ... administration (MDA)
with Zithromax®, the Pfizer, Inc. donated antibiotic,
is a key component of the SAFE strategy, endorsed
by the World Health Organization. There is growing
recognition that improving all aspects of MDA, from
planning to training, recording to reporting, and
receipt of drug to distribution (the supply chain), will
be necessary if MDA programmes are going to reduce
the community burden of Chlamydia trachomatis, and
eliminate trachoma as a cause of blindness by 2020.
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv...
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of re...
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria tar...
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (GMS) has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response,...
Soil-transmitted helminths (STH) affect 1.45 billion people worldwide, and high intensity infections are associated with anemia, undernutrition and impaired cognition, particularly among children. Mathematical models suggest it may be possible to interrupt the transmission of STH in a community by e...
The control and elimination of schistosomiasis have over the last two decades involved several strategies, with the current strategy by the World Health Organization (WHO) focusing mainly on treatment with praziquantel during mass ... administration (MDA). However, the disease context is complex with an interplay of social, economic, political, and cultural factors that may affect achieving the goals of the Neglected Tropical Disease (NTD) 2021-2030 Roadmap. There is a need to revisit the current top-down and reactive approach to schistosomiasis control among sub-Saharan African countries and advocate for a dynamic and diversified approach.
Tuberculosis (TB) and particularly drug-resistant TB continue to represent major public health threats in the WHO European Region. This document details the Tuberculosis action plan for the WHO European Region 2023–2030 as well as its monito...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainsta...
The pharmacological treatment of heart failure has evolved over the last three decades since the demonstration of the effect of angiotensinconverting enzyme inhibitors on major cardiovascular events in patients with heart failure with reduced ejection fraction. Composite analysis of heart failure wi...
